Clinical trials
Completed Univentricular Heart trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 5 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Children's Hospital | 6 |
| Children's Hospital of Philadelphia | 3 |
| Children's Mercy Hospital Kansas City | 3 |
| Emory University | 3 |
| Carelon Research | 1 |
| Children's Healthcare of Atlanta | 1 |
| Duke University | 1 |
| Kevin Hill | 1 |
| Medical College of Wisconsin | 1 |
| Medical University of South Carolina | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Univentricular Heart | 32 |
| Heart Defects, Congenital | 15 |
| Hypoplastic Left Heart Syndrome | 7 |
| Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 2 |
| Heart Failure | 2 |
| Hypertension, Pulmonary | 1 |
| Infant, Newborn, Diseases | 1 |
| Infant, Premature, Diseases | 1 |
| Pleural Effusion | 1 |
| Stress Disorders, Post-Traumatic | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.